Cancer Medicine home

The Department of Cancer Medicine, in partnership with The Alfred and Cabrini Health, transforms cancer care by turning scientific discovery into real-world impact. We're part of the School of Translational Medicine.

About us

We connect world-class researchers, clinicians, data scientists and community partners to accelerate cancer research, from fundamental biology to translational science, clinical trials, and implementation.

Our research

We investigate all tumour types, as well as translational tumour immunology and genomics, experimental therapeutics and fundamental discovery, using state-of-the-art technology and infrastructure.

Clinical trials

With our health service partners, we conduct a comprehensive suite of clinical trials, from surgical studies and first-in-human trials of cutting edge therapies to large, Phase III studies.

Facts and figures

1 in 5 people develop cancer

Worldwide, about 1 in 5 people develop cancer in their lifetime. Lung cancer is the most common (12.4% of all cases) and the leading cause of death from cancer (18%).
One million people diagnosed

In Australia, close to one million people will have been diagnosed with cancer in the past 10 years.
Research infrastructure

Pre-Clinical Imaging, Flow Cytometry, Histology, Microscopy, Genomics, DNA Printing, Bioinformatics, Biostatistics, Registries, Biobanks.
Clinical trials

Australia's largest clinical trials site (The Alfred) and largest private clinical trials provider (Cabrini Health).